These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hormonal management of advanced adenocarcinoma of the prostate. Miles BJ Henry Ford Hosp Med J; 1989; 37(1):16-8. PubMed ID: 2670839 [No Abstract] [Full Text] [Related]
7. [High risk prostate cancer results of one year RT-HT]. Delaporte V; Muracciole X; Lechevalier E; Bastide C; Cowen D; Rossi D; Coulange C Prog Urol; 2005 Dec; 15(6 Suppl 1):1256-61. PubMed ID: 16734214 [No Abstract] [Full Text] [Related]
8. A critical review of the concept of total androgen ablation in the treatment of prostate cancer. Schulze H; Isaacs JT; Coffey DS Prog Clin Biol Res; 1987; 243A():1-19. PubMed ID: 3309968 [No Abstract] [Full Text] [Related]
9. Failure to achieve a PSA level Mitchell DM; McAleese J; Park RM; Stewart DP; Stranex S; Eakin RL; Houston RF; O'Sullivan JM Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1467-71. PubMed ID: 17689886 [TBL] [Abstract][Full Text] [Related]
10. Androgen deprivation therapy for prostate cancer: current status and future prospects. Miyamoto H; Messing EM; Chang C Prostate; 2004 Dec; 61(4):332-53. PubMed ID: 15389811 [TBL] [Abstract][Full Text] [Related]
11. [Keyrole of endocrinology in the victory against prostate cancer]. Labrie F Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238 [TBL] [Abstract][Full Text] [Related]
14. Risk-based management of prostate cancer. D'Amico AV N Engl J Med; 2011 Jul; 365(2):169-71. PubMed ID: 21751910 [No Abstract] [Full Text] [Related]
15. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR; Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313 [TBL] [Abstract][Full Text] [Related]
16. [First line therapy in the treatment of metastatic prostate cancer]. Sakai H; Kanetake H Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704 [TBL] [Abstract][Full Text] [Related]
17. [Management of a hormone dependent cancer with endocrine therapy--prostate cancer]. Tsukamoto S; Akaza H Gan To Kagaku Ryoho; 2001 Jul; 28(7):917-26. PubMed ID: 11478140 [TBL] [Abstract][Full Text] [Related]
18. Complete androgen blockade for the treatment of prostate cancer. Labrie F; Dupont A; Belanger A Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740 [No Abstract] [Full Text] [Related]
19. Prostate-specific antigen halving time while on neoadjuvant androgen deprivation therapy is associated with biochemical control in men treated with radiation therapy for localized prostate cancer. Malik R; Jani AB; Liauw SL Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1022-8. PubMed ID: 20510547 [TBL] [Abstract][Full Text] [Related]
20. Advanced prostate cancer: what's new in hormonal manipulation? Brewster SF; Gillatt DA Br J Hosp Med; 1993 May 19-Jun 1; 49(10):710-1, 714-5. PubMed ID: 7686805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]